Filter
660
Filtered Results: 660
Text search:
K.
Wilson
Featured
Recommendations
61
New Publications
105
Language
Document type
No document type
294
Studies & Reports
160
Guidelines
110
Manuals
43
Strategic & Response Plan
19
Fact sheets
15
Training Material
14
Situation Updates
2
Resource Platforms
2
Brochures
1
Countries / Regions
Global
27
Western and Central Europe
14
South Africa
13
Russia
13
Kenya
12
Latin America and the Carribbean
12
India
12
Brazil
11
Ukraine
10
Uganda
10
Africa
8
Eastern Europe
8
Liberia
7
Tanzania
6
Eastern Europe and Central Asia
6
Sierra Leone
5
Syria
5
Malawi
5
Zimbabwe
5
Germany
5
Middle East and North Africa
5
Ethiopia
5
South Sudan
5
Myanmar / Burma
5
Haiti
4
Bangladesh
4
Zambia
4
Indonesia
4
Colombia
3
Thailand
3
Rwanda
3
Cameroon
3
Nigeria
3
Senegal
3
Philippines
3
Mozambique
3
Armenia
3
South–East Asia Region
3
Spain
3
East and Southern Africa
3
North Macedonia
2
Nepal
2
China
2
Guinea-Bissau
2
Jordan
2
Congo, Democratic Republic of
2
Western Pacific Region
2
United Kingdom
2
Portugal
2
Lebanon
2
Vietnam
2
Yemen
2
Mali
2
Angola
2
Botswana
2
Eswatini/ Swaziland
2
Tajikistan
1
Lesotho
1
Turkey
1
Ghana
1
Chile
1
Estonia
1
Burkina Faso
1
Peru
1
Italy
1
Cambodia
1
Asia
1
Venezuela
1
West and Central Africa
1
Paraguay
1
Gabon
1
Belgium
1
France
1
Belarus
1
Israel
1
Bolivia
1
Argentina
1
Egypt
1
Georgia
1
Honduras
1
Ecuador
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
155
Clinical Guidelines
76
Public Health
53
Women & Child Health
40
Key Resources
14
Capacity Building
10
Pharmacy & Technologies
5
Toolboxes
Mental Health
74
HIV
74
COVID-19
73
TB
46
Planetary Health
45
NCDs
25
AMR
25
Caregiver
24
Disability
23
NTDs
20
Global Health Education
18
Rapid Response
15
Pharmacy
13
Ebola
11
Conflict
10
Refugee
8
Natural Hazards
7
Cholera
5
Health Financing Toolbox
4
Zika
3
Specific Hazards
2
Social Ethics
2
Polio
1
BMJ Global Health2020;5:e001980. doi:10.1136/bmjgh-2019-00198
23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
21 août 2020
Le présent document contient les orientations destinées aux décideurs et aux professionnels de la santé publique et de la santé de
l’enfant pour l’élaboration de politiques relatives au port du masque par les enfants dans le cadre de la pandémie de COVID-19.
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h...
The technical note calls for raising awareness among practitioners and policymakers about the importance of strong tobacco control measures for protecting the health and development of children, including banning tobacco advertising, implementing 100% smoke-free environments and raising taxes on tob...
Available in English, French and Spanish
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidance for the CO...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Working Paper 589 July 2021T
In order to meet changing global population needs and consumer expectations, healthcare systems worldwide are under transformation and face restructuring. As systems adapt and shift their emphasis in response to the disparate requests for healthcare services, oppor-tunities emerge for nurses, especi...
